Cigna Investments Inc United Therapeutics Corp Transaction History

Cigna Investments Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$166.16 - $213.96 $170,480 - $219,522	-1,026 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $84,787 - $99,396	-460 Reduced 30.96%	1,026 $223,000
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $17,986 - $21,488	100 Added 7.22%	1,486 $273,000
Q2 2021 Aug 10, 2021	SELL	$170.47 - $211.93 $34,094 - $42,386	-200 Reduced 12.61%	1,386 $249,000
Q1 2021 May 10, 2021	SELL	$153.94 - $174.85 $10,929 - $12,414	-71 Reduced 4.28%	1,586 $265,000
Q4 2020 Feb 11, 2021	BUY	$101.87 - $151.79 $168,798 - $251,516	1,657 New	1,657 $251,000
Q3 2020 Nov 12, 2020	SELL	$99.9 - $121.13 $226,773 - $274,965	-2,270 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$92.74 - $125.82 $210,519 - $285,611	2,270 New	2,270 $274,000
Q2 2019 Aug 12, 2019	SELL	$76.06 - $120.81 $171,667 - $272,668	-2,257 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$107.15 - $126.84 $241,837 - $286,277	2,257 New	2,257 $264,000
Q1 2018 May 09, 2018	SELL	$107.21 - $151.94 $178,504 - $252,980	-1,665 Closed	0 $0
Q4 2017 Jan 26, 2018	SELL	$118.58 - $151.28 $11,858 - $15,128	-100 Reduced 5.67%	1,665 $246,000
Q3 2017 Oct 11, 2017	BUY	$114.6 - $136.81 $202,269 - $241,469	1,765	1,765 $207,000

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

Stay updated on Cigna Investments Inc with notifications on news.